Efficacy News and Research

RSS

Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222

Researchers evaluated the immunogenicity and safety of the COVID-19 bivalent mRNA vaccine mRNA-1273.222 and tested the neutralizing ability of the two bivalent vaccines — mRNA-1273.222 and mRNA-1273.214 — against the newly emergent Omicron subvariants.

19 Dec 2022

Study: Doctors and their family members less likely to comply with prescription drug guidelines

Following established guidelines about prescription drugs would seem to be an obvious course of action, especially for the professionals that do the prescribing.

18 Dec 2022

Study examines Mpox prevention with modified vaccinia Ankara (MVA)

A new Eurosurveillance study investigated the efficacy of the MVA-BN vaccine, which was administered to individuals after exposure to the virus.

18 Dec 2022

NIH establishes research network to test harm reduction strategies in community settings

To address the overdose crisis in the United States, the National Institutes of Health has established a research network that will test harm reduction strategies in different community settings to inform efforts to help save lives.

16 Dec 2022

Trial results confirm the safety of three different Ebola vaccine regimens

Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to supplement the available data to develop a safe and effective Ebola vaccine strategies in adults and children alike.

16 Dec 2022

Common psychiatric medications can give some protection against COVID-19

A new meta-analysis shows that psychiatric medications can give some protection against COVID-19, with the common antidepressant fluvoxamine showing the strongest effect.

16 Dec 2022

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Researchers investigated the efficacy of ritonavir and nirmatrelvir combination treatment in reducing the risk of COVID-19 severity outcomes such as hospital admissions and deaths when administered during the initial period of SARS-CoV-2 infections.

16 Dec 2022

SARS-CoV-2 Omicron BQ and XBB subvariants show exceptional immune evasion properties

Researchers demonstrated the exceptional immune evasion properties of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants, BQ and XBB.

16 Dec 2022

Is bottled water really safer?

A new study looked at over 500 contaminants and indicators of microbial activity in 30 brands of bottled water and found some evidence that this supposition might be unfounded.

16 Dec 2022

Activated vitamin D3 inhibits arsenic-mediated carcinogenesis in certain skin cells, research shows

According to recent estimates, over 140 million people from 50 countries regularly get exposed to arsenic through drinking water.

16 Dec 2022

Scientists identify a novel epitope at the SARS-CoV-2 spike furin cleavage site

Scientists identify an immunogenic epitope at the furin cleavage site of the SARS-CoV-2 spike protein.

15 Dec 2022

Study finds higher mortality risk in patients with treatment resistant depression

Patients with treatment-resistant depression have a 23 per cent higher risk of death than other depressed patients. They also have twice as much outpatient care and spend three times the number of days in inpatient care.

15 Dec 2022

Sheep milk could be an inexpensive source of therapeutic polyclonal SARS-CoV-2 neutralizing antibodies

Researchers used sheep, a ruminant mammal, to obtain polyclonal immunoglobulins (IgGs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Dec 2022

New project on ultrasound device for treatment of neuropathic pain to receive NIH funding

Researchers from Florida Atlantic University's Schmidt College of Medicine, in collaboration with Albany Medical College in New York, are among seven institutions nationwide selected to receive funding from the National Institutes of Health for their innovative pilot projects to enable new medical devices to diagnose and treat both acute and chronic disorders from neuropathic pain to mental illness.

15 Dec 2022

Efficacy News and Research

Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222

Study: Doctors and their family members less likely to comply with prescription drug guidelines

Study examines Mpox prevention with modified vaccinia Ankara (MVA)

NIH establishes research network to test harm reduction strategies in community settings

Trial results confirm the safety of three different Ebola vaccine regimens

Common psychiatric medications can give some protection against COVID-19

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

SARS-CoV-2 Omicron BQ and XBB subvariants show exceptional immune evasion properties

Is bottled water really safer?

Activated vitamin D3 inhibits arsenic-mediated carcinogenesis in certain skin cells, research shows

Scientists identify a novel epitope at the SARS-CoV-2 spike furin cleavage site

Study finds higher mortality risk in patients with treatment resistant depression

Sheep milk could be an inexpensive source of therapeutic polyclonal SARS-CoV-2 neutralizing antibodies

New project on ultrasound device for treatment of neuropathic pain to receive NIH funding

What is the role of the pediatric gut microbiome in COVID-19?

Study reveals limited effects of longevity treatments on the aging process

The therapeutic effects and safety of psychedelics

Study seeks to look for a better treatment for endometriosis

U-M leads multi-university partnership that aims to predict cognitive fatigue in individuals

Obesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse model

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News